Elizabeta Dudnik
Elizabeta Dudnik publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies and Lung Cancer Research Studies.
- World rank
- #6,431,068 of 7,710,434 ranked researchers
- Rank in United States
- #1,517,118 of 1,627,098
- Works
- 20
- Citations
- 40
- Citations per work
- 2.0
What does Elizabeta Dudnik research?
Elizabeta Dudnik's work is mostly in Medicine (88%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1887.8%
- Medicine1887.8%
- Everything else16.9%
- Life Sciences15.3%
- 1Pulmonary and Respiratory Medicine42% of their works
- 2Oncology37% of their works
- 3Radiology, Nuclear Medicine and Imaging5% of their works
- 4Molecular Biology5% of their works
- 5Genetics2% of their works
- 6Cardiology and Cardiovascular Medicine2% of their works
Research topics
Which keywords describe Elizabeta Dudnik's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Cetuximab, KRAS Mutations and Metastasis.
- Trastuzumab
- HER2
- Palbociclib
- Immune Checkpoint Blockade
- Small-Cell Lung Cancer
- Genomic Profiles
- Tumor Microenvironment
- Metastasis
- Cetuximab
- ALK Inhibitors
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- EGFR Mutations
- KRAS Mutations
- Breast Cancer
- CT Screening
- Lung Cancer
- CDK4/6 Inhibitors
- PD-1 and PD-L1
- Cancer
- Inflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Chemotherapy174 topics
- Clinical Trials162 topics
- Targeted Therapy162 topics
- ALK Inhibitors121 topic
- EGFR Mutations121 topic
- Cetuximab71 topic
- KRAS Mutations71 topic
- Metastasis62 topics
- Breast Cancer52 topics
- Tumor Microenvironment52 topics
- CT Screening41 topic
- Genomic Profiles41 topic
- Lung Cancer41 topic
- Small-Cell Lung Cancer41 topic
- CDK4/6 Inhibitors31 topic
- Immune Checkpoint Blockade31 topic
- PD-1 and PD-L131 topic
- Palbociclib31 topic
- Cancer21 topic
- HER221 topic
- Inflammation21 topic
- Trastuzumab21 topic
Where does Elizabeta Dudnik work?
Elizabeta Dudnik's main affiliation in the publication record is Hadassah, United States.
How many publications and citations does Elizabeta Dudnik have?
OpenAlex counts 20 works and 40 citations for Elizabeta Dudnik, an h-index of 4, ranking #6,431,068 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elizabeta Dudnik. Posts are plain text and can be reported.